Table 1: Baseline measures.

Patient characteristicDiabetics ( )

Gender (M/F)28/28
ASA dose (81 mg/325 mg)48/8
Prior CVD8/58 (14%)
Smoking, (%)7/49 (14%)
Age (years)
BMI (kg/m2)
Medication (%) 
 ACE inhibitors or ARB36%
 Statin51%
 Insulin43%
Waist circumference (cm)
Systolic BP (mmHg)
Diastolic BP (mmHg)
11-dh-TxB2 (pg/mg creatinine)
 ASA-S (%)64%
VerifyNow (ARU)
 ASA-S (%)82%
LDL (mg/dL)
HDL (mg/dL)
TG (mg/dL)
Creatinine (mg/dL)
HbA1c %
Fasting Glucose (mg/dL)
Duration of diabetes (years)

Values are presented in means ± SE.
11-dh-TxB2:  Urine thromboxane, ARU: Aspirin resistance units, TG:  Triglyceride, LDL: Low density lipoproteins, HDL: High density lipoprotein, ASA-S: Aspirin sensitive, ARB: Angiotensin receptor blocker, ACE: Angiotensin converting enzyme.